Evidence map›Paper›PMID 37830377›Full record

ArticleMaternal & child nutrition2024

Comparison between the for-profit human milk industry and nonprofit human milk banking: Time for regulation?

Natalie Shenker, Jonathan Linden, Betty Wang, Claudia Mackenzie, Alex Pueyo Hildebrandt, Jacqui Spears, Danielle Davis, Sushma Nangia, Gillian Weaver

Open access · goldAbstract read
In one paragraph

Article in Maternal & child nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 2 pooled it
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Cost of operating a human milk bank in the UK: a microcosting analysis.Archives of disease in childhood. Fetal and neonatal edition · 2025
    Article
  9. Understanding modifiable barriers to human milk donation in the United Kingdom.Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2025
    Article
  10. Formula protein versus human milk protein and the effects on growth in preterm born infants.Current opinion in clinical nutrition and metabolic care · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Conceptualizing the Commercialization of Human Milk: A Concept Analysis.Journal of human lactation : official journal of International Lactation Consultant Association · 2024
    Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Natalie ShenkerDepartment of Surgery and Cancer, Imperial College London, IRDB, London, UK.
Jonathan LindenCentre for Environmental Policy, Imperial College London, London, UK.
Betty WangCentre for Environmental Policy, Imperial College London, London, UK.
Claudia MackenzieCentre for Environmental Policy, Imperial College London, London, UK.
Alex Pueyo HildebrandtCentre for Environmental Policy, Imperial College London, London, UK.
Jacqui SpearsCentre for Environmental Policy, Imperial College London, London, UK.
Danielle DavisCentre for Environmental Policy, Imperial College London, London, UK.
Sushma NangiaDepartment of Neonatology, Lady Hardinge Medical College, New Delhi, India.ORCID 0000-0002-7664-2259
Gillian WeaverThe Human Milk Foundation, Rothamsted Institute, Herts, Harpenden, UK.ORCID 0000-0002-7556-1852
Imperial College London · GBRothamsted Research · GBLady Hardinge Medical College · IN

Funding

Medical Research Council
6 · The paper itself

Abstract

Human milk (HM) is a highly evolutionary selected, complex biofluid, which provides tailored nutrition, immune system support and developmental cues that are unique to each maternal-infant dyad. In the absence of maternal milk, the World Health Organisation recommends vulnerable infants should be fed with screened donor HM (DHM) from a HM bank (HMB) ideally embedded in local or regional lactation support services. However, demand for HM products has arisen from an increasing awareness of the developmental and health impacts of the early introduction of formula and a lack of prioritisation into government-funded and nonprofit milk banking and innovation. This survey of global nonprofit milk bank leaders aimed to outline the trends, commonalities and differences between nonprofit and for-profit HM banking, examine strategies regarding the marketing and placement of products to hospital and public customers and outline the key social, ethical and human rights concerns. The survey captured information from 59 milk bank leaders in 30 countries from every populated continent. In total, five companies are currently trading HM products with several early-stage private milk companies (PMCs). Products tended to be more expensive from PMC than HMB, milk providers were financially remunerated and lactation support for milk providers and recipients was not a core function of PMCs. Current regulatory frameworks for HM vary widely, with the majority of countries lacking any framework, and most others placing HM within food legislation, which does not include the support and care of milk donors and recipient prioritisation. Regulation as a Medical Product of Human Origin was only in place to prevent the sale of HM in four countries; export and import of HM was banned in two countries. This paper discusses the safety and ethical concerns raised by the commodification of HM and the opportunities policymakers have globally and country-level to limit the potential for exploitation and the undermining of breastfeeding.

Indexed as

Milk BanksMilk, HumanBreast FeedingFemaleHumansInfantOrganizations, NonprofitWorld Health Organizationbreastfeedingdonor milkexploitationinfant nutritionmarketsneonatologypaediatricsregulationWHO Code

Identifiers

PMID37830377
PMCPMC10749996
OpenAlexW4387598765

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.